tirzepatide and eyes Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Tirzepatide Diabetic Retinopathy Risk: Monitoring

GIP promotes clearance of circulating triglycerides and free fatty acids and enhances adipose tissue triglyceride absorption, serving as a crucial hormonal regulator of postprandial triglyceride response in humans (173175)

Higher average weight loss compared to many older therapies Potential improvements in cardiovascular and liver health Multifactorial action: impacts metabolism, appetite, and fat storage Might help treat related conditions such as sleep apnea and chronic pain Less frequent dosing due to longer half-life Better results may be achieved with retatrutide in the care of a physician, especially for those who have not responded to therapies currently available

While semaglutide can be very effective, like all medications, it comes with potential side effects

Studies show these medications: Lower total cholesterol, LDL cholesterol, and triglyceride levels 10 Reduce small- and medium-sized LDL particles, which are particularly harmful 10 Promote cholesterol efflux from cells through increased ABCA1 expression 11 Liraglutide and taspoglutide demonstrate exceptional cholesterol-lowering effects, especially on total cholesterol and triglycerides 10

Selling or promoting retatrutide in the UK is illegal under the Human Medicines Regulations 2012